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HypoxemiaAbstract Introduction: Currently Extracorporeal Membrane Oxygenation (ECMO) is used for
long-term support of respiratory and/or cardiac function, ECMO is primarily indicated for patients
with temporary severe ventilation and/or oxygenation problems that they are unlikely to survive
conventional lung protective mechanical ventilation.
Aim of the work: We describe our experience in the management of a case of opioid-induced
acute respiratory distress syndrome with ECMO.
Methods: A 22 year old female, known Heroin addict, admitted with severe ARDS, failed to
improve with conventional ventilation, Murray Lung Injury Score was 3.5, RESP score (8) was
4, underwent Veno-venous (V-V) ECMO via femoro-atrial approach using Maquet Cardiohelp
console. The ECMO run duration was 12 days. Successful decannulation was done after weaning
off ECMO by decreasing FiO2 on ECMO, and continuing mechanical ventilation on pressure
support ventilation.
Results: Successful weaning of ECMO on day 12 and successful extubation on day 14.
Conclusion: ECMO can be used safely and successfully in the treatment of Heroin induced
ARDS.
 2016 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Currently Extracorporeal Membrane Oxygenation (ECMO) is
used for long-term support of respiratory and/or cardiac func-
tions. ECMO is primarily indicated for patients with tempo-
rary severe ventilation and/or oxygenation problems who are
unlikely to survive conventional lung protective mechanical
ventilation [1,2]. Examples of such patients include those with
40 A.A. Said et al.the acute respiratory distress syndrome (ARDS) without major
non-pulmonary organ failure who are failing mechanical ven-
tilation or suffering from major barotrauma that hinders effec-
tive ventilation [3,4]. ECMO is most useful when the primary
lung insult is reversible in the absence of the usual oxygen tox-
icity and barotraumas caused by conventional ventilatory sup-
port. In adults, the proof was clearly illustrated in the CESAR
trial in 2009, which showed survival beneﬁt in severe ARDS
patients transferred to an ECMO center when compared to
receiving standard therapy in their ICUs [5].
Opioid overdose has been implicated as a cause of ARDS
[6]. Patients with opioid-induced non cardiogenic pulmonary
edema (NCPE) or ARDS can have severe hypoxemia fre-
quently needing invasive mechanical ventilation.
Our case demonstrates an infrequently seen respiratory
complication in opioid overdose. Timely management deci-
sions about adequate use of reversal agents and considering
early mechanical ventilation in severely hypoxemic patients
can be lifesaving, but when refractory hypoxia ensues on
mechanical ventilation, ECMO support should be deployed
[7].
2. Case report
A 22 year old female, heavy cigarette and shisha smoker,
known Heroin addict, with a history of Deep venous thrombo-
sis and pulmonary embolism 1 year prior to admission. The
patient was admitted to a private hospital with progressive
dyspnea and severe hypoxemia. Initial noninvasive ventilation
failed to improve oxygenation, and the patient was invasively
ventilated using lung protective strategy according to ARDS
network guidelines. Chest X ray showed bilateral lung inﬁl-
trates (Fig. 1). The following day, surgical emphysema was
noticed, and though pneumothorax wasn’t clinically or radio-
logically relevant, bilateral intercostal tubes were inserted.
Arterial blood gas (ABG) analysis showed respiratory aci-
dosis with pH 7.27, partial pressure of carbon dioxide (PaCO2)
at 55 mm Hg, partial pressure of oxygen (PaO2) at 40 mm Hg,
HCO3 of 25 mEq/l and SpO2 of 66%.
She was transferred to our center for the possibility of
ECMO on 1st of March 2015. When admitted she was sedated,Figure 1 Chest X ray before institution of ECMO support.paralyzed and maintained on vasopressors (Norepinephrine
0.1 lg/kg/min) with stable hemodynamic proﬁle (blood pres-
sure 120/70 mm Hg, heart rate 125 beat/min, temperature
36.8 C and Central Venous Pressure 8 cm H2O). With inter-
mittent sedation vacation done, she was fully conscious.
Murray Lung Injury Score was 3.5 (PaO2/FIO2 ratio was
36, 3 quadrants affected in CXR, PEEP was 16 cm H2O and
lung compliance was 18 ml/cm H2O).
Laboratory proﬁle showed normal serum electrolytes and
renal function. TLC was 32 103/ml. Drug screening in urine
which was sampled in the referring hospital was positive for
opiates. Naloxone was empirically given in the referring hospi-
tal on admission with no signiﬁcant clinical or radiologic
improvement.
Prone positioning was tried with no improvement in oxy-
genation. Arterial blood gases showed pH 7.39, PCO2
49 mm Hg, PO2 36 mm Hg, HCO3 27.9 mEq/l and O2 satura-
tion 68%.
Decision was taken to initiate Veno-venous (V-V) ECMO
after her father’s consent. The patient RESP score [8] was 4
(age 18–49 years, initiation of mechanical ventilation instituted
within 48 h before initiation of ECMO, Neuromuscular block-
ers were used before initiation of ECMO) correlating with sur-
vival of 65–85%.
Percutaneous cannulation was done via femoro-femoral
approach using drainage left femoral Maquet cannula
(23f/38 cm) and return right femoral Maquet cannula
(21f/55 cm). The cannulae position was veriﬁed with CXR
and ultrasonography (Fig. 2). Maquet Cardiohelp console
was utilized.
The ﬂow during the ﬁrst 24 h was about 120 ml/kg/min.
Mechanical ventilation during ECMO was on pressure con-
trolled ventilation with peak inspiratory pressure of 15 cm H2-
O, PEEP 10 cm H2O, and FiO2 40%. Tidal volume ranged
between 65 and 70 ml.
Anticoagulation with unfractionated heparin by intra-
venous infusion was initiated reaching a PTT of 50–60 s.Figure 2 Chest X ray after improvement on ECMO support.
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aureus and corresponding antibiotics were instituted.
The ECMO run duration was 12 days. Early surgical tra-
cheostomy was done on day 8. By day 11, there was improve-
ment in chest X-ray, marked improvement in lung compliance
(65 ml/cm H2O) and improved oxygenation (PaO2/FIO2 ratio
was 365) Fig. 2.
Successful decannulation was done after weaning off
ECMO by decreasing FiO2 on ECMO on day 11, and contin-
uing mechanical ventilation on pressure support ventilation
Fig. 3.
The patient was weaned from mechanical ventilation on
day 14 and tracheostomy removed two days later. The patient
was discharged home on day 21.
3. Discussion
This is a case fulﬁlling the criteria of severe ARDS with refrac-
tory hypoxemia despite being ventilated according to ARDS-
Net protocol, She can beneﬁt from V-V ECMO support
according to ELSO guidelines especially the presence of totally
reversible cause like Heroin induced ARDS. Mechanical venti-
lation less than 7 days carries a favorable outcome [9,10].
Venovenous femoro-jugular percutaneous cannulation
approach has been previously shown to be better than other
approaches [11]. However due to massive surgical emphysema
involving the upper half of the body in this patient we used the
femoro-femoral approach.
Weaning from V-V ECMO is done through keeping same
ﬂow to avoid oxygenator thrombosis followed by decreasing
ECMO FIO2 over 24 h then decannulation if we have satisfac-
tory blood gases on low requirement mechanical ventilation
[12]. This protocol minimizes the risk of circuit thrombosis
induced by low ﬂow.
Sporer and Dorn described 27 patients of non-cardiogenic
pulmonary edema (NCPE) secondary to heroin overdose
[13]. Overall, clinical presentation of opioid-induced ARDS
is generally indistinguishable from other causes of ARDS.
The presence of frothy, sometimes blood tinged pulmonary
secretions and bilateral diffuse inﬁltrates on chest radiograph
are characteristic. Occasionally, it may be necessary to demon-
strate normal cardiac pump function through measurements of
serum BNP levels, echocardiogram and rarely right heart
catheterization. The mechanisms behind opioid induced NCPE
or ARDS remain largely unknown. The role of increased pul-Figure 3 Chest X ray after decannulation.monary capillary permeability due to hypoxemia, potent his-
tamine release and respiratory acidosis caused by depression
of medullary respiratory centers have been implicated [14,15].
Interestingly, the use of reversal agents like naloxone itself
has also been described as the primary cause of pulmonary
edema [16].
An early orotracheal intubation should be considered in
obtunded or severely hypoxemic patients. Following intuba-
tion, general management strategies used in any form of
ARDS comprising lung protective strategies of ventilation,
appropriate PEEP and diuretics are used. Overall prognosis
remains good with most patients recovering within 24 h.
Although rarely needed ECMO may be lifesaving in severe
cases when mechanical ventilation fails to maintain adequate
gas exchange.
In our patient the initial lung affection didn’t seem to be
pulmonary edema and the progressive course to severe ARDS
can be explained by superadded infectious etiology due to
impurities in the inhaled narcotic mixture, which was proved
by positive sputum culture for Staph. in addition to unhealthy
lungs induced by heavy cigarette smoking.
4. Conclusion
ECMO was used safely and successfully in treatment of Heroin
induced severe ARDS refractory to mechanical ventilation.
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